Evaluation of Regorafenib in Newly Diagnosed and Recurrent Glioblastoma: GBM AGILE Phase II/III Bayesian Randomized Platform Trial

14 Apr 20264 min read0 viewsJournal Feed

GIST

Journal of Clinical Oncology, Ahead of Print.

Clinical Editorial

Summary

Journal of Clinical Oncology (JCO) published a clinical update in Oncology on 14 Apr 2026. The item focuses on Evaluation of Regorafenib in Newly Diagnosed and Recurrent Glioblastoma: GBM AGILE Phase II/III Bayesian Randomized Platform Trial. Open the detail page to review the full original feed content.